market-trends is the sole category represented across all 1 tracked stories. Humira is most often covered alongside AbbVie, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 3 original sources each against 4 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Humira
market-trends is the sole category represented across all 1 tracked stories. Humira is most often covered alongside AbbVie, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 3 original sources each against 4 for the same window. Their average consequence score of 7 runs above the beat's 5.7 for that window. Humira appears in 1 tracked Healthcare story from February 25, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Humira. Shared-story counts are live from our verified record — not editorial picks.
AbbVie has announced a $380 million investment to expand its North Chicago manufacturing campus, marking the first major step in a $100 billion decade-long commitment to U.S. R&D. The initiative aims to localize active pharmaceutical ingredient production while integrating with the Trump administration's 'TrumpRx' program to lower drug costs.
Humira is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.